Saving and improving lives by solving the world’s health problems.
- The first use of human cell cloning to study genetics and cancer.
- The development of the first vaccine for shingles.
- The first liver transplant ever performed in the world.
Home to these groundbreaking medical discoveries and many more, CU Anschutz is driven by the multidisciplinary approach of our researchers and clinicians across the spectrum of science and medicine, from innovative cancer clinical trials to examining the benefits of equine therapy for children with autism.
As one of only a handful of integrated health science campuses in the country, our researchers, clinicians, faculty and students can explore the most critical questions in healthcare with the facilities to support the entire spectrum of research, from the lab to patient application in a single unique environment.
With two top nationally ranked partner hospitals on the campus, alongside several specialty clinics and centers, and supported by hundreds of millions of dollars in research grants, there is support and momentum for new ideas from inception to implementation.
For researchers, this means connections to abundant research opportunities and a network of collaborative relationships with specialists and leaders in their fields.
For patients, it means faster, easier access to the newest, most innovative treatments.
Learn more about the research conducted at CU Anschutz and see why experts from around the world come to our campus to pursue their health innovation goals.
Recent Discoveries by Our Researchers & Clinicians
Learn about some of the most impactful breakthroughs happening here on campus.
CU Researchers Awarded Grant for Musculoskeletal Research Training Program
The new training program will be the only such program in the Rocky Mountain region
Research Shows Low Patient Comprehension of Terms Commonly Found in Electronic Health Information
Survey respondents showed a low understanding of terms such as “carcinoma” and “metastatic” commonly found in breast pathology reports.
Lipid Nanoparticles Show Significant Promise in Carrying Cancer Drugs to Tumors
Cancer Center researcher Dmitri Simberg, PhD, is focusing on penetrating the blood-brain barrier in glioblastoma to more effectively deliver anti-cancer therapies.
Emphasizing The Importance of Patient Navigation
CU Cancer Center members and leaders were key contributors to an American Cancer Society supplement on patient navigation.
Learn More About the Research Conducted at CU Anschutz
Explore how research and clinical trials take shape and how discoveries become real world applications.
